Article
Cardiac & Cardiovascular Systems
Masayoshi Yamamoto, Yoshihiro Seo, Tomoko Ishizua, Daishi Nakagawa, Kimi Sato, Tomoko Machino-Ohtsuka, Isao Nishi, Yoshie Hamada-Harimura, Seika Sai, Akinori Sugano, Masako Baba, Haruhiko Higuchi, Kazutaka Aonuma, Nobuyuki Ohte, Masaki Ieda
Summary: This study showed that sST2 can predict cardiovascular events in patients with heart failure, especially in those with preserved ejection fraction. Other biomarkers such as PTX3, Gal-3, and high-sensitivity troponin T did not demonstrate significant predictive value after adjustment for clinical variables.
JOURNAL OF CARDIAC FAILURE
(2021)
Article
Cardiac & Cardiovascular Systems
Roberta Florido, Lucia Kwak, Justin B. Echouffo-Tcheugui, Sui Zhang, Erin D. Michos, Vijay Nambi, Ronald B. Goldberg, Ron C. Hoogeveen, Mariana Lazo, Gary Gerstenblith, Wendy S. Post, Roger S. Blumenthal, Josef Coresh, Aaron R. Folsom, Elizabeth Selvin, Christie Ballantyne, Chiadi E. Ndumele
Summary: This study found a strong association between obesity and galectin-3, a biomarker of cardiac inflammation and fibrosis. The combination of obesity and elevated galectin-3 is associated with a significantly increased risk of heart failure.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2022)
Article
Chemistry, Analytical
Trey W. Pittman, Xi Zhang, Chamindie Punyadeera, Charles S. Henry
Summary: Heart failure is a growing epidemic and a significant clinical and public health problem. Researchers have developed a portable and affordable diagnostic device for heart failure that can be used at the point-of-care, providing a valid alternative to current diagnostics approaches.
SENSORS AND ACTUATORS B-CHEMICAL
(2024)
Article
Cardiac & Cardiovascular Systems
Alessia Gallo, Valentina Agnese, Sergio Sciacca, Cesare Scardulla, Manlio Cipriani, Michele Pilato, Jae K. Oh, Salvatore Pasta, Joseph Maalouf, Pier Giulio Conaldi, Diego Bellavia
Summary: This study aimed to identify circulating miRNAs that are highly expressed in myocardial tissue and significantly associated with echocardiographic and hemodynamic measures in patients with heart failure. miR-30d was correlated with left ventricular volumes, miR-126-3p was associated with pulmonary artery pressure and pulmonary capillary wedge pressure, and miR-483-3p had an association with right ventricular end diastolic diameter and central venous pressure.
Review
Cardiac & Cardiovascular Systems
Yujiao Shi, Guoju Dong, Jiangang Liu, Xiong Shuang, Chunqiu Liu, Chenguang Yang, Wang Qing, Wenbo Qiao
Summary: This meta-analysis indicates that plasma Galectin-3 (Gal-3) is strongly associated with the risk of new-onset heart failure with preserved ejection fraction (HFpEF), adverse outcomes in HFpEF patients, and the severity of cardiac structural abnormality and left ventricular diastolic dysfunction (LVDD) in HFpEF populations.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Cardiac & Cardiovascular Systems
Qun Lu, Ruo-Chen Zhang, Shu-Ping Chen, Tao Li, Ya Wang, Yan-Bo Xue, Jing Liu, Xiu Han, Yi-Dan Su, Ling Bai, Xiao-Jun Du, Ai-Qun Ma
Summary: Plasma galectin 3 (Gal-3) in heart failure patients with different etiologies has diagnostic and prognostic value, with its expression in cardiac tissues and plasma affecting its significance. Gal-3 is associated with TIMP-1 and echocardiographic parameters in heart failure patients.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2021)
Article
Cardiac & Cardiovascular Systems
Jesse D. Cochran, Yoshimitsu Yura, Mark C. Thel, Heather Doviak, Ariel H. Polizio, Yuka Arai, Yohei Arai, Keita Horitani, Eunbee Park, Nicholas W. Chavkin, Anupreet Kour, Soichi Sano, Nitin Mahajan, Megan Evans, Mahalia Huba, Nadia Martinez Naya, Hanna Sun, Young Ho Ban, Karen K. Hirschi, Stefano Toldo, Antonio Abbate, Todd E. Druley, Frederick L. Ruberg, Mathew S. Maurer, Justin A. Ezekowitz, Jason R. B. Dyck, Kenneth Walsh
Summary: The study identified an enrichment of TET2-mediated CH in patients with HFpEF, which was associated with exacerbated diastolic dysfunction. Patients with HFpEF, aged >= 70 years and CH, exhibited a worse prognosis in terms of 5-year cardiovascular-related hospitalization rate compared with those without CH.
Article
Cardiac & Cardiovascular Systems
Michael J. Mack, JoAnn Lindenfeld, William T. Abraham, Saibal Kar, D. Scott Lim, Jacob M. Mishell, Brian K. Whisenant, Paul A. Grayburn, Michael J. Rinaldi, Samir R. Kapadia, Vivek Rajagopal, Ian J. Sarembock, Andreas Brieke, Jason H. Rogers, Steven O. Marx, David J. Cohen, Neil J. Weissman, Gregg W. Stone
Summary: This study demonstrated that among patients with heart failure and mitral regurgitation, transcatheter mitral valve repair (TMVr) provided effective and sustained reduction in heart failure hospitalizations, mortality, and improved quality of life and functional capacity compared to guideline-directed medical therapy alone through 36 months. Additionally, patients who crossed over to TMVr treatment after 24 months also experienced significant benefits in terms of reduced mortality and heart failure hospitalizations.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
(2021)
Article
Cardiac & Cardiovascular Systems
Emily S. Lau, Elizabeth Liu, Samantha M. Paniagua, Amy A. Sarma, Giovanna Zampierollo, Begona Lopez, Javier Diez, Thomas J. Wang, Jennifer E. Ho
Summary: In this trial, higher Gal-3 levels were associated with female sex, diabetes, and reduced glomerular filtration rate in cross-sectional analyses, but treatment with modified citrus pectin did not change collagen markers. Further investigation is needed for the effect of Gal-3 inhibition among individuals with heart failure.
JACC-BASIC TO TRANSLATIONAL SCIENCE
(2021)
Article
Cardiac & Cardiovascular Systems
Muhammed T. Gurgoze, Laura C. van Vark, Sara J. Baart, Isabella Kardys, K. Martijn Akkerhuis, Olivier C. Manintveld, Douwe Postmus, Hans L. Hillege, Ivonne Lesman-Leegte, Folkert W. Asselbergs, Hans-Peter Brunner-la-Rocca, Ewout J. van den Bos, Joke G. Orsel, Stijn P. J. de Ridder, Yigal M. Pinto, Eric Boersma
Summary: Serially measured GDF-15 predicts the risk of adverse outcomes in acute heart failure during 1-year follow-up. Multiple biomarkers, including GDF-15, should be considered for risk stratification in clinical practice.
CIRCULATION-HEART FAILURE
(2023)
Article
Cardiac & Cardiovascular Systems
Pedro Caravaca Perez, Jose R. Gonzalez-Juanatey, Jorge Nuche, Lucia Matute-Blanco, Isabel Serrano, Manuel Martinez Selles, Rafael Vazquez Garcia, Luis Martinez Dolz, Manuel Gomez-Bueno, Domingo Pascual Figal, Maria G. Crespo-Leiro, Alvaro Garcia-Osuna, Jordi Ordonez-Llanos, Juan Cinca Cuscullola, Jose M. Guerra, Juan F. Delgado
Summary: This study investigated the relationship between the inflammatory marker Galectin-3 and renal function in patients with acute heart failure. The results showed that renal function influences the prognostic value of Galectin-3 levels in these patients.
FRONTIERS IN CARDIOVASCULAR MEDICINE
(2022)
Article
Multidisciplinary Sciences
Momoko Hamano, Seitaro Nomura, Midori Iida, Issei Komuro, Yoshihiro Yamanishi
Summary: The study proposed a trans-omics approach to predict the molecular pathological mechanisms of heart failure and identified Nppa expression levels as a potential diagnostic marker for heart failure. Multiple omics data were integrated to distinguish heterogeneous phenotypes and explore specific gene expression patterns in cardiomyocytes with high Nppa expression.
SCIENTIFIC REPORTS
(2021)
Article
Medicine, General & Internal
Lukasz Wolowiec, Joanna Banach, Jacek Budzynski, Anna Wolowiec, Mariusz Kozakiewicz, Maciej Bielinski, Albert Jasniak, Agata Olejarczyk, Grzegorz Grzesk
Summary: The study aimed to assess the prognostic value of plasma catestatin concentration in patients with heart failure with reduced ejection fraction (HFrEF) in predicting unplanned hospitalization and all-cause death at a 2-year follow-up. The study included 122 hospitalized Caucasian patients in NYHA classes II to IV. Patients who died during the follow-up period had higher levels of CST, NT-proBNP, troponin T, creatinine, and glucose, and lower TAPSE, hemoglobin concentration, hematocrit, and platelet count compared to survivors. Plasma catestatin concentration was positively associated with NYHA class and blood NT-proBNP concentration. Higher plasma catestatin concentration increased the risk of all-cause death by more than five times. Plasma CST concentration is a valuable prognostic parameter in predicting death from all causes and unplanned hospitalization in patients with HFrEF.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Medicine, General & Internal
Magnus Nakrem Lyngbakken, Brede Kvisvik, Trygve Berge, Mohammad Osman Pervez, Erika Nerdrum Aagaard, Inger Ariansen, Torbjorn Omland, Arnljot Tveit, Kjetil Steine, Helge Rosjo
Summary: This study assessed the relationship between serial blood pressure measurements and the risk of cardiovascular disease. The results showed that serial blood pressure measurements are more closely associated with left ventricular remodeling and cardiovascular outcomes than individual blood pressure measurements.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
(2023)
Article
Cardiac & Cardiovascular Systems
Alberto Aimo, Iacopo Fabiani, Giuseppe Vergaro, Chiara Arzilli, Vladyslav Chubuchny, Emilio Maria Pasanisi, Christina Petersen, Elisa Poggianti, Claudia Taddei, Nicola Riccardo Pugliese, Antoni Bayes-Genis, Josep Lupon, Alberto Giannoni, Andrea Ripoli, Georgios Georgiopoulos, Claudio Passino, Michele Emdin
Summary: The study found that an increase in left ventricular ejection fraction of >10 U and an increase in LVEF >= 1 category are stronger predictors of cardiovascular death than LVESV reduction >= 15%.